Houston (1)

COL6A3 Positive (1)

HLA-A*0201 Positive Cells Present (1)

PRAME Positive (1)

Recurrent Ovarian Carcinoma (1)

Active, not recruiting (1)

phase 1 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

aldesleukin (1)

cd8-positive t-lymphocyte (1)

cyclophosphamide (1)

leukapheresis (1)

utomilumab (1)

biological (1)

drug (1)

procedure (1)

Other (1)

Interventional (1)

prame positive

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Sep 22, 2022